CD44v6 monoclonal antibody-conjugated gold nanostars for targeted photoacoustic imaging and plasmonic photothermal therapy of gastric cancer stem-like cells

Theranostics

Volumn 5, Issue 9, 2015, Pages 970-984

  Liang, Shujing ^a,b   Li, Chao ^b   Zhang, Chunlei ^b   Chen, Yunsheng ^b   Xu, Liang ^a   Bao, Chenchen ^b   Wang, Xiaoyong ^c   Liu, Gang ^c   Zhang, Fengchun ^a,d   Cui, Daxiang ^b  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b Shanghai Jiao Tong University   (China)

^c XIAMEN UNIVERSITY   (China)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

CD44v6 monoclonal antibody; Gastric cancer stem cells (GCSCs); Gold nanostars; Photoacoustic imaging; Photothermal therapy

Indexed keywords

ANTINEOPLASTIC AGENT; CD44V6 MONOCLONAL ANTIBODY CONJUGATED GOLD NANOSTAR; HERMES ANTIGEN; NANOMATERIAL; UNCLASSIFIED DRUG; CD44V6 ANTIGEN; GOLD; MONOCLONAL ANTIBODY; NANOPARTICLE;

ABLATION THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; CANCER CELL; CANCER INHIBITION; CANCER THERAPY; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG STRUCTURE; DYNAMIC LIGHT SCATTERING; ENERGY DISPERSIVE X RAY; FEASIBILITY STUDY; GASTRIC CANCER STEM LIKE CELL; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; LIGHT SCATTERING; MASS SPECTROMETRY; MOUSE; NANOFABRICATION; NEAR INFRARED SPECTROSCOPY; NONHUMAN; OUTCOME ASSESSMENT; PHOTOACOUSTICS; PHOTOTHERMAL ABLATION; PLASMONIC PHOTOTHERMAL THERAPY; SCANNING ELECTRON MICROSCOPY; STOMACH CANCER; TARGETED PHOTOACOUSTIC IMAGING; TRANSMISSION ELECTRON MICROSCOPY; TUMOR XENOGRAFT; ULTRAVIOLET SPECTROSCOPY; X RAY; ANIMAL; DISEASE MODEL; DRUG DELIVERY SYSTEM; FLUORESCENCE IMAGING; HUMAN; IMMUNOLOGY; INFRARED RADIATION; LOW LEVEL LASER THERAPY; NUDE MOUSE; PROCEDURES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; THERANOSTIC NANOMEDICINE; THERMOTHERAPY; TREATMENT OUTCOME;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD44; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; GOLD; HUMANS; HYPERTHERMIA, INDUCED; INFRARED RAYS; LOW-LEVEL LIGHT THERAPY; MICE, NUDE; NANOPARTICLES; OPTICAL IMAGING; PHOTOACOUSTIC TECHNIQUES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; THERANOSTIC NANOMEDICINE; TREATMENT OUTCOME;

EID: 84946062744     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.11632     Document Type: Article

References (58)

1. Cancer IAfRo. Globocan 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. World Health Organization http://globocan iarc fr/Pages/fact_sheets_cancer aspx Accessed on. 2014; 9.
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013; 63: 11-30.
3. Chen WQ, Zheng RS, Zhang SW, Zeng HM, Zou XN. The incidences and mortalities of major cancers in china, 2010. Chin J Cancer. 2014; 33: 402-5.
4. Takahashi T, Saikawa Y, Kitagawa Y. Gastric cancer: Current status of diagnosis and treatment. Cancers (Basel). 2013; 5: 48-63.
5. Vinogradov S, Wei X. Cancer stem cells and drug resistance: The potential of nanomedicine. Nanomedicine (Lond). 2012; 7: 597-615.
6. Zhang D, Fan D. New insights into the mechanisms of gastric cancer multidrug resistance and future perspectives. Future Oncol. 2010; 6: 527-37.
7. Stojnev S, Krstic M, Ristic-Petrovic A, Stefanovic V, Hattori T. Gastric cancer stem cells: Therapeutic targets. Gastric Cancer. 2013.
8. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, et al. Cancer stem cells-perspectives on current status and future directions: Aacr workshop on cancer stem cells. Cancer Res. 2006; 66: 9339-44.
9. Gilbertson RJ, Graham TA. Cancer: Resolving the stem-cell debate. Nature. 2012; 488: 462-3.
10. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, et al. A cell initiating human acute myeloid leukaemia after transplantation into scid mice. Nature. 1994; 367: 645-8.
11. Takaishi S, Okumura T, Tu S, Wang SS, Shibata W, Vigneshwaran R, et al. Identification of gastric cancer stem cells using the cell surface marker cd44. Stem Cells. 2009; 27: 1006-20.
12. Clement V, Marino D, Cudalbu C, Hamou MF, MLynarik V, de Tribolet N, et al. Marker-independent identification of glioma-initiating cells. Nat Methods. 2010; 7: 224-8.
13. Liu J, Ma L, Xu J, Liu C, Zhang J, Liu J, et al. Spheroid body-forming cells in the human gastric cancer cell line mkn-45 possess cancer stem cell properties. International Journal of Oncology. 2013; 42: 453-9.
14. Li R, Wu X, Wei H, Tian S. Characterization of side population cells isolated from the gastric cancer cell line sgc-7901. Oncol Lett. 2013; 5: 877-83.
15. Xue Z, Yan H, Li J, Liang S, Cai X, Chen X, et al. Identification of cancer stem cells in vincristine preconditioned sgc7901 gastric cancer cell line. Journal of Cellular Biochemistry. 2012; 113: 302-12.
16. Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T. Opinion: Migrating cancer stem cells-an integrated concept of malignant tumour progression. Nat Rev Cancer. 2005; 5: 744-9.
17. Duan JJ, Qiu W, Xu SL, Wang B, Ye XZ, Ping YF, et al. Strategies for isolating and enriching cancer stem cells: Well begun is half done. Stem Cells and Development. 2013; 22: 2221-39.
18. Marhaba R, Klingbeil P, Nuebel T, Nazarenko I, Buechler MW, Zoeller M. Cd44 and epcam: Cancer-initiating cell markers. Curr Mol Med. 2008; 8: 784-804.
19. Prud'Homme GJ. Cancer stem cells and novel targets for antitumor strategies. Curr Pharm Des. 2012; 18: 2838-49.
20. Chen T, Yang K, Yu J, Meng W, Yuan D, Bi F, et al. Identification and expansion of cancer stem cells in tumor tissues and peripheral blood derived from gastric adenocarcinoma patients. Cell Res. 2012; 22: 248-58.
21. Zhang C, Li C, He F, Cai Y, Yang H. Identification of cd44+cd24+ gastric cancer stem cells. J Cancer Res Clin Oncol. 2011; 137: 1679-86.
22. Chen W, Zhang X, Chu C, Cheung WL, Ng L, Lam S, et al. Identification of cd44+ cancer stem cells in human gastric cancer. Hepatogastroenterology. 2013; 60: 949-54.
23. Misra S, Heldin P, Hascall VC, Karamanos NK, Skandalis SS, Markwald RR, et al. Hyaluronan-cd44 interactions as potential targets for cancer therapy. FEBS J. 2011; 278: 1429-43.
24. Yoshida M, Yasuda T, Hiramitsu T, Ito H, Nakamura T. Induction of apoptosis by anti-cd44 antibody in human chondrosarcoma cell line sw1353. Biomed Res. 2008; 29: 47-52.
25. Jang BI, Li Y, Graham DY, Cen P. The role of cd44 in the pathogenesis, diagnosis, and therapy of gastric cancer. Gut Liver. 2011; 5: 397-405.
26. Heider KH, Kuthan H, Stehle G, Munzert G. Cd44v6: A target for antibody- based cancer therapy. Cancer Immunol Immunother. 2004; 53: 567-79.
27. Chen Y, Huang K, Li X, Lin X, Zhu Z, Wu Y. Generation of a stable anti-human cd44v6 scfv and analysis of its cancer-targeting ability in vitro. Cancer Immunol Immunother. 2010; 59: 933-42.
28. Naor D, Sionov RV, Ish-Shalom D. Cd44: Structure, function, and association with the malignant process. Adv Cancer Res. 1997; 71: 241-319.
29. Wang X, Yang L, Chen ZG, Shin DM. Application of nanotechnology in cancer therapy and imaging. CA Cancer J Clin. 2008; 58: 97-110.
30. Dong K, Liu Z, Li Z, Ren J, Qu X. Hydrophobic anticancer drug delivery by a 980nm laser-driven photothermal vehicle for efficient synergistic therapy of cancer cells in vivo. Adv Mater. 2013; 25: 4452-8.
31. Yang X, Liu X, Liu Z, Pu F, Ren J, Qu X. Near-infrared light-triggered, targeted drug delivery to cancer cells by aptamer gated nanovehicles. Adv Mater. 2012; 24: 2890-5.
32. Kim C, Song HM, Cai X, Yao J, Wei A, Wang LV. In vivo photoacoustic mapping of lymphatic systems with plasmon-resonant nanostars. J Mater Chem. 2011; 21: 2841-4.
33. Wang S, Huang P, Nie L, Xing R, Liu D, Wang Z, et al. Single continuous wave laser induced photodynamic/plasmonic photothermal therapy using photosensitizer- functionalized gold nanostars. Adv Mater. 2013; 25: 3055-61.
34. Chen R, Wang X, Yao X, Zheng X, Wang J, Jiang X. Near-ir-triggered photothermal/ photodynamic dual-modality therapy system via chitosan hybrid nanospheres. Biomaterials. 2013; 34: 8314-22.
35. Yuan H, Khoury CG, Hwang H, Wilson CM, Grant GA, Vo-Dinh T. Gold nanostars: Surfactant-free synthesis, 3d modelling, and two-photon photoluminescence imaging. Nanotechnology. 2012; 23: 075102.
36. Park J, Ku M, Kim E, Park Y, Hong Y, Haam S, et al. Cd44-specific supramolecular hydrogels for fluorescence molecular imaging of stem-like gastric cancer cells. Integr Biol (Camb). 2013; 5: 669-72.
37. Zieker D, Buhler S, Ustundag Z, Konigsrainer I, Manncke S, Bajaeifer K, et al. Induction of tumor stem cell differentiation-novel strategy to overcome therapy resistance in gastric cancer. Langenbecks Arch Surg. 2013; 398: 603-8.
38. Choi J, Yang J, Bang D, Park J, Suh JS, Huh YM, et al. Targetable gold nanorods for epithelial cancer therapy guided by near-ir absorption imaging. Small. 2012; 8: 746-53.
39. Yuan H, Khoury CG, Wilson CM, Grant GA, Bennett AJ, Vo-Dinh T. In vivo particle tracking and photothermal ablation using plasmon-resonant gold nanostars. Nanomedicine. 2012; 8: 1355-63.
40. Van de Broek B, Devoogdt N, D'Hollander A, Gijs HL, Jans K, Lagae L, et al. Specific cell targeting with nanobody conjugated branched gold nanoparticles for photothermal therapy. ACS Nano. 2011; 5: 4319-28.
41. Park J, Ku M, Kim E, Park Y, Hong Y, Haam S, et al. Cd44-specific supramolecular hydrogels for fluorescence molecular imaging of stem-like gastric cancer cells. Integrative Biology. 2013; 5: 669-72.
42. Jin L, Hope KJ, Zhai Q, Smadja-Joffe F, Dick JE. Targeting of cd44 eradicates human acute myeloid leukemic stem cells. Nat Med. 2006; 12: 1167-74.
43. Burke AR, Singh RN, Carroll DL, Wood JC, D'Agostino Jr. RB, Ajayan PM, et al. The resistance of breast cancer stem cells to conventional hyperthermia and their sensitivity to nanoparticle-mediated photothermal therapy. Biomaterials. 2012; 33: 2961-70.
44. Lee E, Hong Y, Choi J, Haam S, Suh JS, Huh YM, et al. Highly selective cd44-specific gold nanorods for photothermal ablation of tumorigenic subpopulations generated in mcf7 mammospheres. Nanotechnology. 2012; 23: 465101.
45. Wang CH, Chiou SH, Chou CP, Chen YC, Huang YJ, Peng CA. Photothermolysis of glioblastoma stem-like cells targeted by carbon nanotubes conjugated with cd133 monoclonal antibody. Nanomedicine. 2011; 7: 69-79.
46. Weissleder R. A clearer vision for in vivo imaging. Nat Biotechnol. 2001; 19: 316-7.
47. Pan B, Cui D, Xu P, Ozkan C, Feng G, Ozkan M, et al. Synthesis and characterization of polyamidoamine dendrimer-coated multi-walled carbon nanotubes and their application in gene delivery systems. Nanotechnology. 2009; 20: 125101.
48. Huang P, Xu C, Lin J, Wang C, Wang X, Zhang C, et al. Folic acid-conjugated graphene oxide loaded with photosensitizers for targeting photodynamic therapy. Theranostics. 2011; 1: 240-50.
49. Li Z, Huang P, Zhang X, Lin J, Yang S, Liu B, et al. Rgd-conjugated dendrimer- modified gold nanorods for in vivo tumor targeting and photothermal therapy. Mol Pharm. 2010; 7: 94-104.
50. Nie L, Wang S, Wang X, Rong P, Ma Y, Liu G, et al. In vivo volumetric photoacoustic molecular angiography and therapeutic monitoring with targeted plasmonic nanostars. Small. 2014; 10: 1585-93.
51. Nie L, Chen X. Structural and functional photoacoustic molecular tomography aided by emerging contrast agents. Chem Soc Rev. 2014; 43: 7132-70.
52. Li W, Sun X, Wang Y, Niu G, Chen X, Qian Z, et al. In vivo quantitative photoacoustic microscopy of gold nanostar kinetics in mouse organs. Biomedical optics express. 2014; 5: 2679-85.
53. Nie L, Huang P, Li W, Yan X, Jin A, Wang Z, et al. Early-stage imaging of nanocarrier-enhanced chemotherapy response in living subjects by scalable photoacoustic microscopy. ACS Nano. 2014; 8: 12141-50.
54. Dondapati SK, Sau TK, Hrelescu C, Klar TA, Stefani FD, Feldmann J. Label- free biosensing based on single gold nanostars as plasmonic transducers. ACS Nano. 2010; 4: 6318-22.
55. Gutrath BS, Beckmann MF, Buchkremer A, Eckert T, Timper J, Leifert A, et al. Size-dependent multispectral photoacoustic response of solid and hollow gold nanoparticles. Nanotechnology. 2012; 23: 225707.
56. Chen YS, Frey W, Aglyamov S, Emelianov S. Environment-dependent generation of photoacoustic waves from plasmonic nanoparticles. Small. 2012; 8: 47-52.
57. Cheng Y, Meyers JD, Broome AM, Kenney ME, Basilion JP, Burda C. Deep penetration of a pdt drug into tumors by noncovalent drug-gold nanoparticle conjugates. Journal of The American Chemical Society. 2011; 133: 2583-91.
58. Sykes EA, Chen J, Zheng G, Chan WC. Investigating the impact of nanoparticle size on active and passive tumor targeting efficiency. ACS Nano. 2014; 8: 5696-706.